Patents by Inventor Tom Vandenberghe

Tom Vandenberghe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Targeting of interleukin-1 and -18 signaling in treatment of septic shock
    Patent number: 9919048
    Abstract: The present invention relates to the inactivation of interleukin-1 and interleukin-18 signaling in treatment of inflammation and septic shock. More specifically, it relates to a sequential or simultaneous application of both an interleukin-1 receptor antagonist and an interleukin-18 antibody. In one preferred embodiment, a combination treatment of an IL-1 receptor antagonist and an IL-18 antibody is used.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: March 20, 2018
    Assignees: VIB VZW, UNIVERSITEIT GENT
    Inventors: Peter Vandenabeele, Anje Cauwels, Tom Vandenberghe
  • TARGETING OF INTERLEUKIN-1 AND -18 SIGNALING IN TREATMENT OF SEPTIC SHOCK
    Publication number: 20160331837
    Abstract: The present invention relates to the inactivation of interleukin-1 and interleukin-18 signaling in treatment of inflammation and septic shock. More specifically, it relates to a sequential or simultaneous application of both an interleukin-1 receptor antagonist and an interleukin-18 antibody. In one preferred embodiment, a combination treatment of an IL-1 receptor antagonist and an IL-18 antibody is used.
    Type: Application
    Filed: January 15, 2015
    Publication date: November 17, 2016
    Inventors: Peter Vandenabeele, Anje Cauwels, Tom Vandenberghe